Evaluation of Quality of Life and Quality of Sleep in Clinical Practice{A figure is presented}

European Urology, Supplements

Volumn 6, Issue 9, 2007, Pages 576-584

  Chartier Kastler, Emmanuel ^a   Davidson, Kate ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Benign prostatic hyperplasia; Energy; Fatigue; Lower urinary tract symptoms; Nocturia; Quality of life; Quality of sleep; Questionnaire; Vitality

Indexed keywords

ETANERCEPT; EXENDIN 4; INSULIN GLARGINE;

CLINICAL PRACTICE; ENERGY; EVALUATION; FLOW RATE; HUMAN; MICTURITION; NOCTURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SLEEP;

EID: 33846781388     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2007.01.006     Document Type: Review

References (62)

1. Abrams P., Cardozo L., Fall M., et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61 (2003) 37-49
2. Jolleys J.V., Donovan J.L., Nanchahal K., et al. Urinary symptoms in the community: how bothersome are they?. Br J Urol 74 (1994) 551-555
3. Irwin D.E., Milsom I., Hunskaar S., et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50 (2006) 1306-1315
4. Bursztyn M., Jacob J., and Stessman J. Usefulness of nocturia as a mortality risk factor for coronary heart disease among persons born in 1920 or 1921. Am J Cardiol 98 (2006) 1311-1315
5. Asplund R. Nocturia: consequences for sleep and daytime activities and associated risks. Eur Urol Suppl 3 6 (2005) 24-32
6. Irwin M., McClintick J., Costlow C., et al. Partial night sleep deprivation reduces natural killer and cellular immune responses in humans. FASEB J 10 (1996) 643-653
7. Mitropoulos D., Anastasiou I., Giannopoulou C., et al. Symptomatic benign prostate hyperplasia: impact on partners' quality of life. Eur Urol 41 (2002) 240-245
8. Weiss J.P., and Blaivas J.G. Nocturia. J Urol 163 (2000) 5-12
9. Marinkovic S.P., Gillen L.M., and Stanton S.L. Managing nocturia. BMJ 328 (2004) 1063-1066
10. Marschall-Kehrel D. Update on nocturia: the best of rest is sleep. Urology 64 Suppl 6A (2004) 21-24
11. Donovan J.L. Measuring the impact of nocturia on quality of life. BJU Int 84 Suppl 1 (1999) 21-25
12. World Health Organisation. The constitution of the WHO. WHO Chronicle 1947;1:29.
13. Gilhooly M., Gilhooly K., and Bowling A. Quality of life: meaning and measurement. In: Walker A. (Ed). Understanding quality of life in old age (2005), Open University Press, Buckingham
14. MacDonagh R. Quality of life and its assessment in urology. Br J Urol 78 (1996) 485-496
15. Blane D, Wiggins R, Higgs P, et al. Inequalities in quality of life in early old age. GO findings 9, Sheffield: Growing Older Programme. Sheffield (UK): University of Sheffield; 2002.
16. Robinson D, Anders K, Cardozo L, et al. Outcome measures in urogynaecology: the clinicians' perspective. Int Urogynecol J Pelvic Floor Dysfunct 2006. In press.
17. Hunskaar S., and Vinsnes A. The quality of life in women with urinary incontinence as measured by the sickness impact profile. J Am Geriatr Soc 39 (1991) 378-382
18. Grimby A., Milsom I., Molander U., et al. The influence of urinary incontinence on the quality of life of elderly women. Age Ageing 22 (1993) 82-89
19. EuroQol-a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990;16:199-208.
20. Brazier J.E., Harper R., Jones N.M., et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care [see comments]. BMJ 305 (1992) 160-164
21. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 30 (1992) 473-483
22. Ware Jr. J., Kosinski M., and Keller S.D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34 (1996) 220-233
23. Cella D., Yount S., Sorensen M., et al. Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 32 (2005) 811-819
24. Cella D., Lai J.S., Chang C.H., et al. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94 (2002) 528-538
25. Cella D., Eton D.T., Lai J.S., et al. Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage 24 (2002) 547-561
26. Yellen S.B., Cella D.F., Webster K., et al. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13 (1997) 63-74
27. Ibrahim I.A., Beich J., Sidorov J., et al. Measuring outcomes of type 2 diabetes disease management program in an HMO setting. South Med J 95 (2002) 78-87
28. Reza M., Taylor C.D., Towse K., et al. Insulin improves well-being for selected elderly type 2 diabetic subjects. Diabetes Res Clin Pract 55 (2002) 201-207
29. Aggarwal A., Chandran S., and Misra R. Physical, psychosocial and economic impact of rheumatoid arthritis: a pilot study of patients seen at a tertiary care referral center. Natl Med J India 19 (2006) 187-191
30. Hays R.D., and Morales L.S. The RAND-36 measure of health-related quality of life. Ann Med 33 (2001) 350-357
31. Walters S.J., and Brazier J.E. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 14 (2005) 1523-1532
32. Pace M.C., Passavanti M.B., Grella E., et al. Buprenorphine in long-term control of chronic pain in cancer patients. Front Biosci 12 (2007) 1291-1299
33. Otto M, Bach FW, Jensen TS, et al. Health-related quality of life and its predictive role for analgesic effect in patients with painful polyneuropathy. Eur J Pain 2006. In press.
34. Secnik B.K., Matza L.S., Oglesby A., et al. Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes. Health Qual Life Outcomes 4 (2006) 80
35. Tyring S., Gottlieb A., Papp K., et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367 (2006) 29-35
36. Hislop J., and Arber S. Understanding women's sleep management: beyond medicalisation-healthisation?. Sociol Health Illn 25 (2003) 815-837
37. Yi H., Shin K., and Shin C. Development of the sleep quality scale. J Sleep Res 15 (2006) 309-316
38. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14 (1991) 540-545
39. Douglass A.B., Bornstein R., Nino-Murcia G., et al. The Sleep Disorders Questionnaire. I: Creation and multivariate structure of SDQ. Sleep 17 (1994) 160-167
40. Parrott A.C., and Hindmarch I. The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations-a review. Psychopharmacology (Berl) 71 (1980) 173-179
41. van Dijk L., Kooij D.G., Schellevis F.G., et al. Nocturia: impact on quality of life in a Dutch adult population. BJU Int 93 (2004) 1001-1004
42. van Diest R., and Appels W.P. Sleep physiological characteristics of exhausted men. Psychosom Med 56 (1994) 28-35
43. Partinen M., and Gislason T. Basic Nordic Sleep Questionnaire (BNSQ): a quantitated measure of subjective sleep complaints. J Sleep Res 4 (1995) 150-155
44. Buysse D.J., Reynolds III C.F., Monk T.H., et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28 (1989) 193-213
45. Welch G., Weinger K., and Barry M.J. Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study. Urology 59 (2002) 245-250
46. Barry M.J., Fowler F.J., O'Leary M.P., et al. Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of The American Urological Association. Med Care 33 Suppl (1995) AS145-AS155
47. Lukacs B., Comet D., Grange J.C., et al. Construction and validation of a short-form benign prostatic hypertrophy health-related quality-of-life questionnaire. BPH Group in General Practice. Br J Urol 80 (1997) 722-730
48. Barry M.J., Fowler F.J., O'Leary M.P., et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 148 (1992) 1549-1557
49. A comparison of quality of life with patient reported symptoms and objective findings in men with benign prostatic hyperplasia. The Department of Veterans Affairs Cooperative Study of transurethral resection for benign prostatic hyperplasia. J Urol 1993;150:1696-700.
50. Donovan J.L., Kay H.E., Peters T.J., et al. Using the ICSQoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-'BPH' Study. International Continence Society-Benign Prostatic Hyperplasia. Br J Urol 80 (1997) 712-721
51. Epstein R.S., Deverka P.A., Chute C.G., et al. Validation of a new quality of life questionnaire for benign prostatic hyperplasia. J Clin Epidemiol 45 (1992) 1431-1445
52. Girman C.J., Epstein R.S., Jacobsen S.J., et al. Natural history of prostatism: impact of urinary symptoms on quality of life in 2115 randomly selected community men. Urology 44 (1994) 825-831
53. Hald T., Nordling J., Andersen J.T., et al. A patient weighted symptom score system in the evaluation of uncomplicated benign prostatic hyperplasia. Scand J Urol Nephrol Suppl 138 (1991) 59-62
54. Meyhoff H.H., Hald T., Nordling J., et al. A new patient weighted symptom score system (DAN-PSS-1). Clinical assessment of indications and outcomes of transurethral prostatectomy for uncomplicated benign prostatic hyperplasia. Scand J Urol Nephrol 27 (1993) 493-499
55. Chapple C., Batista J.E., Berges R., et al. The impact of nocturia in patients with LUTS/BPH: Need for new recommendations. Eur Urol Suppl 5 (2006) 12-18
56. Abraham L., Hareendran A., Mills I.W., et al. Development and validation of a quality-of-life measure for men with nocturia. Urology 63 (2004) 481-486
57. Avery K., Hashim H., Gardener N., et al. Development and psychometric evaluation of the ICIQ nocturia module: the ICIQ-N. Neurourol Urodyn 23 (2004) 387 (abstract no. 595)
58. Cai T., Gardener N., Abraham L., et al. Impact of surgical treatment on nocturia in men with benign prostatic obstruction. BJU Int 98 (2006) 799-805
59. Bing M.H., Moller L.A., Jennum P., et al. Validity and reliability of a questionnaire for evaluating nocturia, nocturnal enuresis and sleep-interruptions in an elderly population. Eur Urol 49 (2006) 710-719
60. Djavan B., Milani S., Davies J., and Bolodeoku J. The impact of tamsulosin oral controlled absorption system (OCAS) on nocturia and the quality of sleep: preliminary results of a pilot study. Eur Urol Suppl 4 2 (2005) 61-68
61. Sadeh A., Hauri P.J., Kripke D.F., et al. The role of actigraphy in the evaluation of sleep disorders. Sleep 18 (1995) 288-302
62. Edinger J.D., Means M.K., Stechuchak K.M., et al. A pilot study of inexpensive sleep-assessment devices. Behav Sleep Med 2 (2004) 41-49